Adolescent Covid Vaccine

Adolescents between 12-17 years of age

To evaluate the safety and effectiveness of Novavax Covid19 vaccine vs placebo in adolescents aged 12-17 years old.

Eligibility

• Never diagnosed with Covid19
• Willing to complete diary entries for 2 years
• Willing to have blood drawn from the arm at multiple appointments
• Must be able to have a guardian present at every appointment (8 over 26 months)

Trial Duration

8 office visits over approximately 26 months

Compensation

Compensation varies per appointment